The iStent inject Trabecular Micro-Bypass System, is being called a breakthrough achievement and an exciting option for patients undergoing cataract surgery with glaucoma. Glaucoma, if left untreated, can lead to blindness and is among the leading causes of blindness in the United States. However, with the iStent inject, there is now an advanced option to effectively manage eye pressure associated with glaucoma as well as reduce the reliance on glaucoma medication.

The iStent inject is clinically proven to reduce ocular pressure in patients with cataracts and mild to moderate glaucoma with an excellent safety review, few complications, and quick recovery time.

What is the iStent Inject?

The iStent inject is the latest innovation in trabecular micro-bypass devices designed to improve ocular fluid outflow and lower intraocular pressure. The iStent inject is made up of two tiny implants and are the world’s smallest medical devices to be implanted within the human body.

Intended for use in conjunction with cataract surgery, iStent is the first and only MIGS (Micro-Invasive Glaucoma Surgery) device that creates two bypass pathways in a patient’s trabecular meshwork, relieving intraocular pressure.

Having been implanted in patients all over the world, the iStent has had years of commercial use demonstrating its safety, effectiveness, and consistency. With hundreds of thousands of eyes successfully treated, recent FDA approval for use in the United States marks another major milestone in the advancement of glaucoma therapy.

How Does the iStent Inject Work?

Implanted at the time of cataract surgery, the iStent inject procedure is uncomplicated and minimally invasive to the eye. It carries an overall safety record similar to cataract surgery, one of the most common surgical procedures performed in the United States.

Working together, the two tiny implants create two separate openings (bypasses) between the natural drainage pathway and the front trabecular meshwork of the eye. The implants restore the eye’s ability to adequately drain fluid and have shown to be effective in the decrease of intraocular pressure associated with glaucoma, potentially decreasing a patient’s reliance on glaucoma medication.

During cataract surgery, after your surgeon removes your cataracts, the iStent inject devices will be implanted. Once implanted, patients will not feel or see the devices. The iStent inject, like cataract surgery, is an outpatient procedure meaning you will be able to go home following your surgery.

Who Are Candidates for the iStent Inject Procedure?

The iStent inject procedure is generally reserved for patients experiencing stable, mild to moderate glaucoma who are also undergoing cataract surgery.

  • Patients about to undergo cataract surgery with mild to moderate open-angle glaucoma.
  • Cataract surgery patients who may benefit from lowing their intra-ocular pressure.
  • Patients who may benefit from a decreased risk of intra-ocular pressure changes associated with medication compliance.
  • Patients wishing to avoid risks relating to more invasive surgeries.
  • Patients who are intolerant of or have experienced negative reactions to glaucoma medications.

iStent inject can make a huge difference for the patients who receive it, possibly allowing your doctor to reduce or eliminate your reliance on glaucoma medication.

Learn More About the iStent Inject Today!

Help may be closer than you think. Treatment and control of your glaucoma-related eye pressure are possible without reliance on medication. If you believe you may be a candidate for the iStent inject procedure, call or contact online the expert physicians at Dougherty Laser Vision today. We’re here to answer any questions and provide any information you may need.